Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective

References

• Abu-Dief AM, Alsehli M, Al-Enizi A, Nafady A. (2022). Recent advances in mesoporous silica nanoparticles for targeted drug delivery applications. Curr Drug Deliv 19:1–16. doi: 10.2174/1567201818666210708123007.
   Web of Science ®Google Scholar
• Alagarsamy KN, Yan W, Srivastava A, et al. (2019). Application of injectable hydrogels for cardiac stem cell therapy and tissue engineering. Rev Cardiovasc Med 20:221–30. doi: 10.31083/j.rcm.2019.04.534.
   PubMed Web of Science ®Google Scholar
• Algoet M, Janssens S, Himmelreich U, et al. (2022). Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med 33:357–66. doi: 10.1016/j.tcm.2022.02.005.
   PubMed Web of Science ®Google Scholar
• Ali A, Zafar H, Zia M, et al. (2016). Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl 9:49–67. doi: 10.2147/NSA.S99986.
   PubMed Web of Science ®Google Scholar
• Bietenbeck M, Engel S, Lamping S, et al. (2019). Functionalization of clinically approved MRI contrast agents for the delivery of VEGF. Bioconjug Chem 30:1042–7. doi: 10.1021/acs.bioconjchem.9b00142.
   PubMed Web of Science ®Google Scholar
• Borracci RA, Amrein E, Alvarez Gallesio JM, et al. (2021). Remote ischaemic conditioning in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention: an updated meta-analysis of clinical outcomes. Acta Cardiol 76:623–31. doi: 10.1080/00015385.2020.1766259.
   PubMed Web of Science ®Google Scholar
• Bugger H, Pfeil K. (2020). Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta Mol Basis Dis 1866:165768. doi: 10.1016/j.bbadis.2020.165768.
   PubMed Web of Science ®Google Scholar
• Cai W, Liu L, Shi X, et al. (2023). Alox15/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation 147:1444–60. doi: 10.1161/CIRCULATIONAHA.122.060257.
   PubMed Web of Science ®Google Scholar
• Cao S, Deng Q, Wang Y, et al. (2021). Ultrasound-targeted microbubble destruction-mediated Ang1 gene transfection improves left ventricular structural and sympathetic nerve remodeling in canines with myocardial infarction. Ann Transl Med 9:221–221. doi: 10.21037/atm-20-839.
   PubMed Web of Science ®Google Scholar
• Chen GH, Xu J, Yang YJ. (2017). Exosomes: promising sacks for treating ischemic heart disease? Am J Physiol Heart Circ Physiol 313:H508–H523. doi: 10.1152/ajpheart.00213.2017.
   PubMed Web of Science ®Google Scholar
• Chen J, Song Y, Wang Q, et al. (2022). Targeted neutrophil-mimetic liposomes promote cardiac repair by adsorbing proinflammatory cytokines and regulating the immune microenvironment. J Nanobiotechnology 20:218. doi: 10.1186/s12951-022-01433-6.
   PubMed Web of Science ®Google Scholar
• Chen W, Li D. (2020). Reactive oxygen species (ROS)-responsive nanomedicine for solving ischemia-reperfusion injury. Front Chem 8:732. doi: 10.3389/fchem.2020.00732.
   PubMed Web of Science ®Google Scholar
• Cheng B, Toh EKW, Chen K-H, et al. (2016). Biomimicking platelet-monocyte interactions as a novel targeting strategy for heart healing. Adv Healthc Mater 5:2686–97. doi: 10.1002/adhm.201600724.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Cheng L, Gao X, et al. (2021). Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury. Theranostics 11:861–77. doi: 10.7150/thno.48436.
   PubMed Web of Science ®Google Scholar
• Chenthamara D, Subramaniam S, Ramakrishnan SG, et al. (2019). Therapeutic efficacy of nanoparticles and routes of administration. Biomater Res 23:20. doi: 10.1186/s40824-019-0166-x.
   PubMedGoogle Scholar
• Christman KL, Vardanian AJ, Fang Q, et al. (2004). Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44:654–60. doi: 10.1016/j.jacc.2004.04.040.
   PubMed Web of Science ®Google Scholar
• Cung TT, Morel O, Cayla G, et al. (2015). Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med 373:1021–31. doi: 10.1056/NEJMoa1505489.
   PubMed Web of Science ®Google Scholar
• Du Y, Huo Y, Yang Q, et al. (2023). Ultrasmall iron-gallic acid coordination polymer nanodots with antioxidative neuroprotection for PET/MR imaging-guided ischemia stroke therapy. Exploration (Beijing) 3:20220041. doi: 10.1002/EXP.20220041.
   PubMedGoogle Scholar
• Gao L, Qiu F, Cao H, et al. (2023). Therapeutic delivery of microRNA-125a-5p oligonucleotides improves recovery from myocardial ischemia/reperfusion injury in mice and swine. Theranostics 13:685–703. doi: 10.7150/thno.73568.
   PubMed Web of Science ®Google Scholar
• Gong R, Wu YQ. (2019). Remote ischemic conditioning during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis. J Cardiothorac Surg 14:14. doi: 10.1186/s13019-019-0834-x.
   PubMed Web of Science ®Google Scholar
• Graney PL, Ben-Shaul S, Landau S, et al. (2020). Macrophages of diverse phenotypes drive vascularization of engineered tissues. Sci Adv 6:eaay6391. doi: 10.1126/sciadv.aay6391.
   PubMed Web of Science ®Google Scholar
• Guan Y, Yao W, Yi K, et al. (2021). Nanotheranostics for the management of hepatic ischemia-reperfusion injury. Small 17:e2007727. doi: 10.1002/smll.202007727.
   PubMed Web of Science ®Google Scholar
• Hahn JY, Song YB, Kim EK, et al. (2013). Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation 128:1889–96. doi: 10.1161/CIRCULATIONAHA.113.001690.
   PubMed Web of Science ®Google Scholar
• Han C, Yang J, Sun J, Qin G. (2022). Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications. Pharmacol Ther 233:108025. doi: 10.1016/j.pharmthera.2021.108025.
   PubMed Web of Science ®Google Scholar
• Heusch G, Gersh BJ. (2017). The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 38:774–84. doi: 10.1093/eurheartj/ehw224.
   PubMed Web of Science ®Google Scholar
• Ho LWC, Liu Y, Han R, et al. (2019). Nano-cell interactions of non-cationic bionanomaterials. Acc Chem Res 52:1519–30. doi: 10.1021/acs.accounts.9b00103.
   PubMed Web of Science ®Google Scholar
• Hou M, Wu X, Zhao Z, et al. (2022). Endothelial cell-targeting, ROS-ultrasensitive drug/siRNA co-delivery nanocomplexes mitigate early-stage neutrophil recruitment for the anti-inflammatory treatment of myocardial ischemia reperfusion injury. Acta Biomater 143:344–55. doi: 10.1016/j.actbio.2022.02.018.
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Wang KC, et al. (2015). Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526:118–21. doi: 10.1038/nature15373.
   PubMed Web of Science ®Google Scholar
• Hu CM, Zhang L, Aryal S, et al. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A 108:10980–5. doi: 10.1073/pnas.1106634108.
   PubMed Web of Science ®Google Scholar
• Hu Q, Qian C, Sun W, et al. (2016). Engineered nanoplatelets for enhanced treatment of multiple myeloma and thrombus. Adv Mater 28:9573–80. doi: 10.1002/adma.201603463.
   PubMed Web of Science ®Google Scholar
• Hu S, Wang X, Li Z, et al. (2021). Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury. Nano Today 39:101210. doi: 10.1016/j.nantod.2021.101210.
   PubMed Web of Science ®Google Scholar
• Hui S, Ghergurovich JM, Morscher RJ, et al. (2017). Glucose feeds the TCA cycle via circulating lactate. Nature 551:115–8. doi: 10.1038/nature24057.
   PubMed Web of Science ®Google Scholar
• Ibáñez B, Heusch G, Ovize M, Van de Werf F. (2015). Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol 65:1454–71. doi: 10.1016/j.jacc.2015.02.032.
   PubMed Web of Science ®Google Scholar
• Ikeda G, Matoba T, Ishikita A, et al. (2021). Nanoparticle-mediated simultaneous targeting of mitochondrial injury and inflammation attenuates myocardial ischemia-reperfusion injury. J Am Heart Assoc 10:e019521. doi: 10.1161/JAHA.120.019521.
   PubMed Web of Science ®Google Scholar
• Ikeda G, Matoba T, Nakano Y, et al. (2016). Nanoparticle-mediated targeting of cyclosporine a enhances cardioprotection against ischemia-reperfusion injury through inhibition of mitochondrial permeability transition pore opening. Sci Rep 6:20467. doi: 10.1038/srep20467.
   PubMed Web of Science ®Google Scholar
• Jenča D, Melenovský V, Stehlik J, et al. (2021). Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail 8:222–37. doi: 10.1002/ehf2.13144.
   PubMed Web of Science ®Google Scholar
• Kang M, Jordan V, Blenkiron C, Chamley LW. (2021). Biodistribution of extracellular vesicles following administration into animals: a systematic review. J Extracell Vesicles 10:e12085. doi: 10.1002/jev2.12085.
   PubMed Web of Science ®Google Scholar
• Kaptoge S, Pennells L, DE Bacquer D, et al. (2019). World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. The Lancet Global Health 7:e1332–e1345. doi: 10.1016/S2214-109X(19)30318-3.
   PubMed Web of Science ®Google Scholar
• Kim Y, Nurakhayev S, Nurkesh A, et al. (2021). Macrophage polarization in cardiac tissue repair following myocardial infarction. Int J Mol Sci 22:5. doi: 10.3390/ijms22052715.
   Google Scholar
• Kristen AV, Ackermann K, Buss S, et al. (2013). Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion. Cardiovasc Pathol 22:280–6. doi: 10.1016/j.carpath.2013.01.004.
   PubMed Web of Science ®Google Scholar
• Lan M, Hou M, Yan J, et al. (2022). Cardiomyocyte-targeted anti-inflammatory nanotherapeutics against myocardial ischemia reperfusion (IR) injury. Nano Res 15:9125–34. doi: 10.1007/s12274-022-4553-6.
   PubMed Web of Science ®Google Scholar
• Laurent S, Forge D, Port M, et al. (2008). Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–110. doi: 10.1021/cr068445e.
   PubMed Web of Science ®Google Scholar
• Li F, Liu D, Liu M, et al. (2022a). Tregs biomimetic nanoparticle to reprogram inflammatory and redox microenvironment in infarct tissue to treat myocardial ischemia reperfusion injury in mice. J Nanobiotechnology 20:251. doi: 10.1186/s12951-022-01445-2.
   PubMed Web of Science ®Google Scholar
• Li H, Zhu J, Xu YW, et al. (2022b). Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. Redox Biol 54:102384. doi: 10.1016/j.redox.2022.102384.
   PubMed Web of Science ®Google Scholar
• Li L, Wang Y, Guo R, et al. (2020). Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury. J Control Release 317:259–72. doi: 10.1016/j.jconrel.2019.11.032.
   PubMed Web of Science ®Google Scholar
• Li Q, Song Y, Wang Q, et al. (2021). Engineering extracellular vesicles with platelet membranes fusion enhanced targeted therapeutic angiogenesis in a mouse model of myocardial ischemia reperfusion. Theranostics 11:3916–31. doi: 10.7150/thno.52496.
   PubMed Web of Science ®Google Scholar
• Li W, Wu J, Zhang J, et al. (2018). Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. Drug Deliv 25:827–37. doi: 10.1080/10717544.2018.1455763.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Y, Feng N. (2019). Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert Opin Drug Deliv 16:219–37. doi: 10.1080/17425247.2019.1575806.
   PubMed Web of Science ®Google Scholar
• Liao X, Yang X, Deng H, et al. (2020). Injectable hydrogel-based nanocomposites for cardiovascular diseases. Front Bioeng Biotechnol 8:251. doi: 10.3389/fbioe.2020.00251.
   PubMed Web of Science ®Google Scholar
• Liu C, Su C. (2019). Design strategies and application progress of therapeutic exosomes. Theranostics 9:1015–28. doi: 10.7150/thno.30853.
   PubMed Web of Science ®Google Scholar
• Liu CJ, Yao L, Hu YM, Zhao BT. (2021). Effect of quercetin-loaded mesoporous silica nanoparticles on myocardial ischemia-reperfusion injury in rats and its mechanism. Int J Nanomedicine 16:741–52. doi: 10.2147/IJN.S277377.
   PubMed Web of Science ®Google Scholar
• Liu S, Chen X, Bao L, et al. (2020). Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles. Nat Biomed Eng 4:1063–75. doi: 10.1038/s41551-020-00637-1.
   PubMed Web of Science ®Google Scholar
• Lu Y, Hu Q, Jiang C, Gu Z. (2019). Platelet for drug delivery. Curr Opin Biotechnol 58:81–91. doi: 10.1016/j.copbio.2018.11.010.
   PubMed Web of Science ®Google Scholar
• Luk BT, Zhang L. (2015). Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release 220:600–7. doi: 10.1016/j.jconrel.2015.07.019.
   PubMed Web of Science ®Google Scholar
• Lum AFH, Borden MA, Dayton PA, et al. (2006). Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release 111:128–34. doi: 10.1016/j.jconrel.2005.11.006.
   PubMed Web of Science ®Google Scholar
• Lundy DJ, Chen KH, Toh EK, Hsieh PC. (2016). Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury. Sci Rep 6:25613. doi: 10.1038/srep25613.
   PubMed Web of Science ®Google Scholar
• Lyu Y, Xie J, Liu Y, et al. (2020). Injectable hyaluronic acid hydrogel loaded with functionalized human mesenchymal stem cell aggregates for repairing infarcted myocardium. ACS Biomater Sci Eng 6:6926–37. doi: 10.1021/acsbiomaterials.0c01344.
   PubMed Web of Science ®Google Scholar
• Marin W, Marin D, Ao X, Liu Y. (2021). Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury (Review). Int J Mol Med 47:485–99. doi: 10.3892/ijmm.2020.4823.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Kyoi S, Takagi H, et al. (2008). Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 4:409–15. doi: 10.4161/auto.5638.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Takagi H, Qu X, et al. (2007). Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 100:914–22. doi: 10.1161/01.RES.0000261924.76669.36.
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, et al. (2021). Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20:101–24. doi: 10.1038/s41573-020-0090-8.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Ohsumi Y. (2011). The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 27:107–32. doi: 10.1146/annurev-cellbio-092910-154005.
   PubMed Web of Science ®Google Scholar
• Nguyen MM, Carlini AS, Chien MP, et al. (2015). Enzyme-responsive nanoparticles for targeted accumulation and prolonged retention in heart tissue after myocardial infarction. Adv Mater 27:5547–52. doi: 10.1002/adma.201502003.
   PubMed Web of Science ®Google Scholar
• Nomikou N, Tiwari P, Trehan T, et al. (2012). Studies on neutral, cationic and biotinylated cationic microbubbles in enhancing ultrasound-mediated gene delivery in vitro and in vivo. Acta Biomater 8:1273–80. doi: 10.1016/j.actbio.2011.09.010.
   PubMed Web of Science ®Google Scholar
• Ong S-B, Hernández-Reséndiz S, Crespo-Avilan GE, et al. (2018). Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther 186:73–87. doi: 10.1016/j.pharmthera.2018.01.001.
   PubMed Web of Science ®Google Scholar
• Oroojalian F, Beygi M, Baradaran B, et al. (2021). Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small 17:e2006484. doi: 10.1002/smll.202006484.
   PubMed Web of Science ®Google Scholar
• Ottersbach A, Mykhaylyk O, Heidsieck A, et al. (2018). Improved heart repair upon myocardial infarction: combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes. Biomaterials 155:176–90. doi: 10.1016/j.biomaterials.2017.11.012.
   PubMed Web of Science ®Google Scholar
• Pitchaimani A, Nguyen TDT, Aryal S. (2018). Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy. Biomaterials 160:124–37. doi: 10.1016/j.biomaterials.2018.01.018.
   PubMed Web of Science ®Google Scholar
• Przyklenk K, Dong Y, Undyala VV, Whittaker P. (2012). Autophagy as a therapeutic target for ischaemia/reperfusion injury? Concepts, controversies, and challenges. Cardiovasc Res 94:197–205. doi: 10.1093/cvr/cvr358.
   PubMed Web of Science ®Google Scholar
• Qian L, Thapa B, Hong J, et al. (2018). The present and future role of ultrasound targeted microbubble destruction in preclinical studies of cardiac gene therapy. J Thorac Dis 10:1099–111. doi: 10.21037/jtd.2018.01.101.
   PubMed Web of Science ®Google Scholar
• Qiu C, Han HH, Sun J, et al. (2019). Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes. Nat Commun 10:2702. doi: 10.1038/s41467-019-10562-w.
   PubMed Web of Science ®Google Scholar
• Ramos IT, Henningsson M, Nezafat M, et al. (2018). Simultaneous assessment of cardiac inflammation and extracellular matrix remodeling after myocardial infarction. Circ Cardiovasc Imaging 11:11. doi: 10.1161/CIRCIMAGING.117.007453.
   Web of Science ®Google Scholar
• Romagnuolo R, Masoudpour H, Porta-Sanchez A, et al. (2019). Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias. Stem Cell Reports 12:967–81. doi: 10.1016/j.stemcr.2019.04.005.
   PubMed Web of Science ®Google Scholar
• Salehi B, DEL Prado-Audelo ML, Cortes H, et al. (2020). Therapeutic applications of curcumin nanomedicine formulations in cardiovascular diseases. J Clin Med 9:3. doi: 10.3390/jcm9030746.
   Web of Science ®Google Scholar
• Schober A, Blay RM, Saboor Maleki S, et al. (2021). MicroRNA-21 controls circadian regulation of apoptosis in atherosclerotic lesions. Circulation 144:1059–73. doi: 10.1161/CIRCULATIONAHA.120.051614.
   PubMed Web of Science ®Google Scholar
• Shen D, He Z. (2021). Mesenchymal stem cell-derived exosomes regulate the polarization and inflammatory response of macrophages via miR-21-5p to promote repair after myocardial reperfusion injury. Ann Transl Med 9:1323–1323. doi: 10.21037/atm-21-3557.
   PubMed Web of Science ®Google Scholar
• Shi HT, Huang ZH, Xu TZ, et al. (2022). New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials. EBioMedicine 78:103968. doi: 10.1016/j.ebiom.2022.103968.
   PubMed Web of Science ®Google Scholar
• Skoczeń A, Matusiak K, Setkowicz Z, et al. (2018). Low doses of polyethylene glycol coated iron oxide nanoparticles cause significant elemental changes within main organs. Chem Res Toxicol 31:876–84. doi: 10.1021/acs.chemrestox.8b00110.
   PubMed Web of Science ®Google Scholar
• Smyth T, Kullberg M, Malik N, et al. (2015). Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release 199:145–55. doi: 10.1016/j.jconrel.2014.12.013.
   PubMed Web of Science ®Google Scholar
• Spierings D, Mcstay G, Saleh M, et al. (2005). Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 310:66–7. doi: 10.1126/science.1117105.
   PubMed Web of Science ®Google Scholar
• Su G, Liu L, Yang L, et al. (2018). Homing of endogenous bone marrow mesenchymal stem cells to rat infarcted myocardium via ultrasound-mediated recombinant SDF-1alpha adenovirus in microbubbles. Oncotarget 9:477–87. doi: 10.18632/oncotarget.23068.
   PubMedGoogle Scholar
• Sun L, Huang CW, Wu J, et al. (2013). The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium. Biomaterials 34:2107–16. doi: 10.1016/j.biomaterials.2012.11.041.
   PubMed Web of Science ®Google Scholar
• Sun Z, Xie Y, Lee RJ, et al. (2020). Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction. Theranostics 10:4967–82. doi: 10.7150/thno.43233.
   PubMed Web of Science ®Google Scholar
• Tan H, Song Y, Chen J, et al. (2021). Platelet-like fusogenic liposome-mediated targeting delivery of miR-21 improves myocardial remodeling by reprogramming macrophages post myocardial ischemia-reperfusion injury. Adv Sci (Weinh) 8:e2100787.
   PubMedGoogle Scholar
• Tardif J-C, Kouz S, Waters DD, et al. (2019). Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381:2497–505. doi: 10.1056/NEJMoa1912388.
   PubMed Web of Science ®Google Scholar
• Traverse JH, Henry TD, Dib N, et al. (2019). First-in-man study of a cardiac extracellular matrix hydrogel in early and late myocardial infarction patients. JACC Basic Transl Sci 4:659–69. doi: 10.1016/j.jacbts.2019.07.012.
   PubMedGoogle Scholar
• Unger E, Porter T, Lindner J, Grayburn P. (2014). Cardiovascular drug delivery with ultrasound and microbubbles. Adv Drug Deliv Rev 72:110–26. doi: 10.1016/j.addr.2014.01.012.
   PubMed Web of Science ®Google Scholar
• Valikeserlis I, Athanasiou AA, Stakos D. (2021). Cellular mechanisms and pathways in myocardial reperfusion injury. Coron Artery Dis 32:567–77. doi: 10.1097/MCA.0000000000000997.
   PubMed Web of Science ®Google Scholar
• VAN Wamel A, Kooiman K, Harteveld M, et al. (2006). Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 112:149–55. doi: 10.1016/j.jconrel.2006.02.007.
   PubMed Web of Science ®Google Scholar
• Wang K, Jiang Z, Webster KA, et al. (2017). Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal MicroRNA-21. Stem Cells Transl Med 6:209–22. doi: 10.5966/sctm.2015-0386.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhou T, Xu M, et al. (2022a). Platelet membrane-camouflaged nanoparticles carry microRNA inhibitor against myocardial ischaemia–reperfusion injury. J Nanobiotechnology 20:434. doi: 10.1186/s12951-022-01639-8.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen Y, Zhao Z, et al. (2018). Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J Am Heart Assoc 7:e008737.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang D, Wu C, et al. (2022b). MMP 9-instructed assembly of bFGF nanofibers in ischemic myocardium to promote heart repair. Theranostics 12:7237–49. doi: 10.7150/thno.77345.
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhu M, Li S, et al. (2021). Engineered biomimetic nanoplatform protects the myocardium against ischemia/reperfusion injury by inhibiting pyroptosis. ACS Appl Mater Interfaces 13:33756–66. doi: 10.1021/acsami.1c03421.
   PubMed Web of Science ®Google Scholar
• Weng X, Tan H, Huang Z, et al. (2022). Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia-reperfusion injury. J Nanobiotechnology 20:454. doi: 10.1186/s12951-022-01652-x.
   PubMed Web of Science ®Google Scholar
• Wu MY, Yiang GT, Liao WT, et al. (2018). Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem 46:1650–67. doi: 10.1159/000489241.
   PubMed Web of Science ®Google Scholar
• Wu X, Li Y, Zhang S, Zhou X. (2021). Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics 11:3052–9. doi: 10.7150/thno.54113.
   PubMed Web of Science ®Google Scholar
• Xia W, Yan T, Wen L, et al. (2022). Hypothermia-Triggered Mesoporous Silica Particles for Controlled Release of Hydrogen Sulfide to Reduce the I/R Injury of the Myocardium. ACS Biomater Sci Eng 8:2970–8. doi: 10.1021/acsbiomaterials.2c00266.
   PubMedGoogle Scholar
• Xiang M, Lu Y, Xin L, et al. (2021). Role of oxidative stress in reperfusion following myocardial ischemia and its treatments. Oxid Med Cell Longev 2021:6614009–23. doi: 10.1155/2021/6614009.
   PubMed Web of Science ®Google Scholar
• Xie D-M, Zhong Q, Xu X, et al. (2023). Alpha lipoic acid–loaded electrospun fibrous patch films protect heart in acute myocardial infarction mice by inhibiting oxidative stress. Int J Pharm 632:122581. doi: 10.1016/j.ijpharm.2023.122581.
   PubMedGoogle Scholar
• Xiong YY, Gong ZT, Tang RJ, Yang YJ. (2021). The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction. Theranostics 11:1046–58. doi: 10.7150/thno.53326.
   PubMed Web of Science ®Google Scholar
• Yajima S, Miyagawa S, Fukushima S, et al. (2019). Prostacyclin analogue-loaded nanoparticles attenuate myocardial ischemia/reperfusion injury in rats. JACC Basic Transl Sci 4:318–31. doi: 10.1016/j.jacbts.2018.12.006.
   PubMedGoogle Scholar
• Yu CG, Deng Q, Cao S, et al. (2022). Ultrasound-targeted cationic microbubbles combined with the NFkappaB binding motif increase SDF-1alpha gene transfection: A protective role in hearts after myocardial infarction. Kaohsiung J Med Sci 38:594–604. doi: 10.1002/kjm2.12529.
   PubMed Web of Science ®Google Scholar
• Zargar SM, Hafshejani DK, Eskandarinia A, et al. (2019). A review of controlled drug delivery systems based on cells and cell membranes. J Med Signals Sens 9:181–9. doi: 10.4103/jmss.JMSS_53_18.
   PubMedGoogle Scholar
• Zhang K, Zhao X, Chen X, et al. (2018). Enhanced therapeutic effects of mesenchymal stem cell-derived exosomes with an injectable hydrogel for hindlimb ischemia treatment. ACS Appl Mater Interfaces 10:30081–91. doi: 10.1021/acsami.8b08449.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wei Q, Liu X, et al. (2021a). Exosomal microRNA-98-5p from hypoxic bone marrow mesenchymal stem cells inhibits myocardial ischemia-reperfusion injury by reducing TLR4 and activating the PI3K/Akt signaling pathway. Int Immunopharmacol 101:107592. doi: 10.1016/j.intimp.2021.107592.
   PubMed Web of Science ®Google Scholar
• Zhang T, Dang M, Zhang W, Lin X. (2020). Gold nanoparticles synthesized from Euphorbia fischeriana root by green route method alleviates the isoprenaline hydrochloride induced myocardial infarction in rats. J Photochem Photobiol B 202:111705. doi: 10.1016/j.jphotobiol.2019.111705.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cai Z, Shen Y, et al. (2021b). Hydrogel-load exosomes derived from dendritic cells improve cardiac function via Treg cells and the polarization of macrophages following myocardial infarction. J Nanobiotechnology 19:271. doi: 10.1186/s12951-021-01016-x.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ren X, Wang Y, et al. (2021c). Targeting ferroptosis by polydopamine nanoparticles protects heart against ischemia/reperfusion injury. ACS Appl Mater Interfaces 13:53671–82. doi: 10.1021/acsami.1c18061.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu D, Wei Y, et al. (2019). A collagen hydrogel loaded with HDAC7-derived peptide promotes the regeneration of infarcted myocardium with functional improvement in a rodent model. Acta Biomater 86:223–34. doi: 10.1016/j.actbio.2019.01.022.
   PubMed Web of Science ®Google Scholar
• Zhao J, Li X, Hu J, et al. (2019). Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res 115:1205–16. doi: 10.1093/cvr/cvz040.
   PubMed Web of Science ®Google Scholar
• Zhao T, Wu W, Sui L, et al. (2022). Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact Mater 7:47–72. doi: 10.1016/j.bioactmat.2021.06.006.
   PubMed Web of Science ®Google Scholar
• Zhong S, Shu S, Wang Z, et al. (2012). Enhanced homing of mesenchymal stem cells to the ischemic myocardium by ultrasound-targeted microbubble destruction. Ultrasonics 52:281–6. doi: 10.1016/j.ultras.2011.08.013.
   PubMed Web of Science ®Google Scholar
• Zhou J, Yang X, Liu W, et al. (2018). Injectable OPF/graphene oxide hydrogels provide mechanical support and enhance cell electrical signaling after implantation into myocardial infarct. Theranostics 8:3317–30. doi: 10.7150/thno.25504.
   PubMed Web of Science ®Google Scholar
• Zhou T, Yang X, Wang T, et al. (2022). Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia-Reperfusion Injury. Membranes (Basel) 12:6. doi: 10.3390/membranes12060605.
   Web of Science ®Google Scholar
• Zhou Z, Sun Y, Shen J, et al. (2014). Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy. Biomaterials 35:7470–8. doi: 10.1016/j.biomaterials.2014.04.063.
   PubMed Web of Science ®Google Scholar
• Zhu K, Yao Y, Wang K, et al. (2023). Berberin sustained-release nanoparticles were enriched in infarcted rat myocardium and resolved inflammation. J Nanobiotechnology 21:33. doi: 10.1186/s12951-023-01790-w.
   PubMed Web of Science ®Google Scholar
• Ziegler M, Wang X, Lim B, et al. (2017). Platelet-targeted delivery of peripheral blood mononuclear cells to the ischemic heart restores cardiac function after ischemia-reperfusion injury. Theranostics 7:3192–206. doi: 10.7150/thno.19698.
   PubMed Web of Science ®Google Scholar
• Zielińska A, Carreiró F, Oliveira AM, et al. (2020). Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules 25:3731. doi: 10.3390/molecules25163731.
   PubMed Web of Science ®Google Scholar